Article Details

Moleculin Biotech (NASDAQ:MBRX) Given a $3.00 Price Target at Maxim Group

Retrieved on: 2019-08-23 18:07:30

Tags for this article:

Click the tags to see associated articles and topics

Moleculin Biotech (NASDAQ:MBRX) Given a $3.00 Price Target at Maxim Group. View article details on hiswai:

Excerpt

<div><b>Vanguard Group</b> Inc. grew its stake in Moleculin Biotech by 235.4% in the second quarter. <b>Vanguard Group</b> Inc. now owns 2,680,010 shares of the ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up